Email Not Verified

Action Required

Please go to your profile settings and make sure your email is verified before applying for account verification.

Please refer to the documentation here.

Confirm Account Verification

Final Step

Please make sure you have filled in all the required details.

We need these details to verify your account. Once you click Yes, we will send an account activation request to our team.

Please refer to the documentation here.

Incomplete Profile

Missing Information Required

Here are all required fields. Complete the remaining ones before applying:

Back to Top
Go Back
Journal Photo for Diabetes Technology and Therapeutics
Peer reviewed only Open Access

Diabetes Technology and Therapeutics (DTT)

Publisher : Sage Publishing
Diabetes Mellitus Endocrinology Diabetes Technology
Claim Your Journal Get PRC Visit Website
e-ISSN 1557-8593
p-ISSN 1520-9156
Issue Frequency Bi-Monthly
Est. Year 1999
Mobile 18054990721
Language English
APC YES
Email journals@sagepub.com

Journal Descriptions

Diabetes Technology & Therapeutics is an international, peer-reviewed journal dedicated to research and innovation in diabetes care through advanced technologies and therapeutic approaches. Since its establishment in 1999, the journal has become a leading publication for endocrinologists, diabetologists, biomedical engineers, clinical researchers, and healthcare professionals interested in improving diabetes management. It publishes original research articles, systematic reviews, clinical investigations, technical reports, editorials, and special issues covering the latest developments in diabetes technology. The journal emphasizes innovative tools and treatments including continuous glucose monitoring (CGM), insulin pumps, artificial pancreas systems, smart insulin delivery devices, digital health, telemedicine, wearable sensors, mobile health applications, artificial intelligence, decision-support software, and precision medicine. It also features studies on new insulin formulations, glucose-lowering therapies, behavioral interventions, and long-term prevention of diabetic complications. The journal promotes interdisciplinary collaboration between clinicians, engineers, computer scientists, and industry experts to advance diabetes care. It is widely indexed in major databases such as MEDLINE/PubMed, Scopus, EMBASE, and the Science Citation Index Expanded (SCIE), making it an influential source of evidence-based research in endocrinology and diabetes technology.

Diabetes Technology and Therapeutics (DTT) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Diabetes Mellitus, Endocrinology, Diabetes Technology, Continuous Glucose Monitoring, Insulin Pumps, Artificial Pancreas Systems, Digital Health, Telemedicine, Medical Devices, Biomedical Engineering, Artificial Intelligence in Healthcare, Diabetes Therapeutics, continuous glucose monitoring (CGM), insulin pumps, artificial pancreas systems, smart insulin delivery devices, digital health, telemedicine, wearable sensors, mobile health applications, artificial intelligence, decision-support software, precision medicine , Online or Print , Bi-Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1520-9156, E-ISSN: 1557-8593, Established: 1999,
  • Does Not Provide Crossref DOI

  • Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE